These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23677504)

  • 1. [Medial calcific sclerosis under long-term anticoagulation with vitamin K antagonists].
    Walther B
    Dtsch Med Wochenschr; 2013 May; 138(21):1102-6. PubMed ID: 23677504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular calcification: the price to pay for anticoagulation therapy with vitamin K-antagonists.
    Chatrou ML; Winckers K; Hackeng TM; Reutelingsperger CP; Schurgers LJ
    Blood Rev; 2012 Jul; 26(4):155-66. PubMed ID: 22520397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of anticoagulation before stroke on stroke severity and long-term survival.
    Haeusler KG; Konieczny M; Endres M; Villringer A; Heuschmann PU
    Int J Stroke; 2012 Oct; 7(7):544-50. PubMed ID: 22111868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Derailed oral anticoagulation with very high INR values and poor response to oral vitamin K--cholestasis as a possible cause].
    Fontana S; Zeerleder S; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):477-80. PubMed ID: 10517112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of vitamin K antagonists and risk of subarachnoid haemorrhage: a population-based case-control study.
    Olsen M; Johansen MB; Christensen S; Sørensen HT
    Eur J Intern Med; 2010 Aug; 21(4):297-300. PubMed ID: 20603039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stroke prevention in atrial fibrillation. Marcumar alternative in sight].
    Einecke D
    MMW Fortschr Med; 2009 Sep; 151(38):12-4. PubMed ID: 19831172
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticoagulation with the low-molecular-weight heparin dalteparin (Fragmin) in atrial fibrillation and TEE-guided cardioversion.
    Bechtold H; Gunzenhauser D; Sawitzki H; Fung S; Janssen D
    Z Kardiol; 2003 Jul; 92(7):532-9. PubMed ID: 12883837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical decision-making for vitamin K-1 and K-2 deficiency and coronary artery calcification with warfarin therapy: are diet, factor Xa inhibitors or both the answer?
    Wahlqvist ML; Tanaka K; Tzeng BH
    Asia Pac J Clin Nutr; 2013; 22(3):492-6. PubMed ID: 24066371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excessive anticoagulation with warfarin or phenprocoumon may have multiple causes.
    Meegaard PM; Holck LH; Pottegård A; Madsen H; Hallas J
    Dan Med J; 2012 Feb; 59(2):A4383. PubMed ID: 22293053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Off-label use in long-term anticoagulation after liver transplantation due to phenprocoumon-induced hepatic failure].
    Bertsche T; Fritz R; Sauer P; Encke J; Haefeli WE; Walter-Sack I
    Med Klin (Munich); 2005 Dec; 100(12):820-4. PubMed ID: 16453097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anticoagulation and atrial fibrillation].
    Simmers TA
    Tijdschr Gerontol Geriatr; 2012 Dec; 43(6):308-12. PubMed ID: 23371873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conservative anticoagulation].
    Bischoff A
    MMW Fortschr Med; 2016 Mar; 158(4):16. PubMed ID: 27119861
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between dietary vitamin K intake and the stability of anticoagulation effect in patients taking long-term warfarin.
    Kim KH; Choi WS; Lee JH; Lee H; Yang DH; Chae SC
    Thromb Haemost; 2010 Oct; 104(4):755-9. PubMed ID: 20664899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of long-term anticoagulation. Narrow margin between effectiveness and risk].
    Stiefelhagen P
    MMW Fortschr Med; 2004 Sep; 146(39):I-X; quiz XI-XII. PubMed ID: 15532419
    [No Abstract]   [Full Text] [Related]  

  • 16. Problems in anticoagulation of a patient with antibiotic treatment for endocarditis: interaction of rifampicin and vitamin K antagonists.
    Mizera L; Geisler T; Mörike K; Gawaz M; Steeg M
    BMJ Case Rep; 2018 Feb; 2018():. PubMed ID: 29440136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics).
    Poli D; Antonucci E; Zanazzi M; Grifoni E; Testa S; Ageno W; Palareti G
    Thromb Haemost; 2012 Jun; 107(6):1100-6. PubMed ID: 22535516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How can we improve long-term anticoagulation?].
    Beck EA
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1495-500. PubMed ID: 4081678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding rates in patients older than 90 years of age on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tincani E; Baldini P; Crowther MA; Zanasi A; Ferrari P; Cenci AM; Rioli G
    Blood Coagul Fibrinolysis; 2009 Jan; 20(1):47-51. PubMed ID: 20523164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.